glp-1 drug boom Receptor Agonist Market Size Ease your GLP Americans are taking weight-loss drugs

As GLP-1 agonists have garnered attention for management of obesity due to their effect on reducing insulin sensitivity, they are now being considered a therapeutic option for the treatment of PCOS (polycystic ovarian syndrome), one of the most common causes of subfertility, diagnosed via Rotterdams criteria: oligomenorrhea, hyperandrogenism and polycystic ovaries (97)

Furthermore, disruption of adherens junctions, including E-cadherin and -catenin, rapidly decreases gap junction plaques, leading to reduced Cx32 levels

Results have been good, especially for inflammation and general recovery

However, there are a few exceptions and we recommend speaking with a B12 LOVE Functional Medicine Practitioner before deciding on an IV Drip